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Background: Liver transplantation is a life-saving intervention for many patients with end-stage liver disease. In the past, evaluation of successful liver transplantation was based on patients’ survival rate. However, in recent years this evaluation has been based on patients’ quality of life. Various instruments have been developed to evaluate patients’ quality of life. Nonetheless, scholars still believe that it is crucial to develop a standardized and disease specific instrument for evaluating the quality of life in liver transplant recipients.
Objectives: The aim of this paper was to describe the development and psychometric testing process of a quality of life instrument specific to liver transplant recipients.
Materials and Methods: Initial items of this instrument were extracted from a conventional content analysis study, and then were completed with findings of related international literature. The face validity was assessed by interviewing with four liver transplant recipients, and the content validity was evaluated by eleven experts in the field of transplantation. The construct validity was achieved by involving 250 liver transplant recipients through exploratory factor analysis method, and reliability was calculated by Cronbach's alpha.
Results: Three main factors with 40 items were extracted from the exploratory factor analysis: Health Satisfaction, Concerns, and Complications. Reliability of the instrument was confirmed (alpha = 0.922).
Conclusions: Given the special considerations regarding liver transplant recipients, this questionnaire is more accurate in evaluating the success of liver transplantation.
Keywords: Liver Transplantation; Quality of Life; Questionnaire
Implication for health policy/practice/research/medical education:It is clear that the use of this questionnaire instead of the common tools can be viewed as a more accurate criterion to assess the outcomes of liver trans-plants.Copyright © 2013, Kowsar Corp.; Published by Kowsar. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. BackgroundLiver transplantation is a life-saving intervention for many patients with end-stage liver disease. In the past, evaluating the outcome of liver transplants was based on patients’ survival rate. Statistical information shows that the survival rate of liver transplant recipients has sig-nificantly grown in the past two decades due to develop-ments in the treatment and care, so that now the survival rate in the first and the fifth years after transplantation are 90% and 70% respectively (1, 2).With recent improvements in patients’ survival rate and graft as the primary indicators of successful liver trans-plants, health care professionals have been paying more attention to other indicators of a successful liver trans-plant such as recurrence of underlying disease, trans-plant’s complications, and recipients’ quality of life (3); in fact, improving patients’ survival rate is not the only 
purpose of liver transplant procedure. Recovering the pa-tients’ social disability and improving their quality of life are the most expected outcomes of this intervention. The quality of life measure provides a set of useful practical information about the patients’ health status for health care professionals. This measure is an important param-eter in assessing diseases’ effects and also evaluating the impact of medical interventions on the overall perfor-mance of individuals’ life. Regarding liver transplanta-tion, assessing patients’ quality of life offers information about the desirable and undesirable consequences of re-lated predictive factors (4, 5). Since evaluating patients’ quality of life has an important role in diseases’ manage-ments, various instruments have been developed (6). An accurate estimate of quality of life is strongly dependent on the psychometric properties of developed instrument to measure this construct.
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1.1. Necessity of Developing a Specific Liver Trans-
plantation InstrumentMany studies have been intended to use quality of life in liver transplant recipients. For this reason, they tried to employ different instruments to measure this con-struct. Jay and his colleagues conducted a systematic review to evaluate the currently available quality of life instruments used in liver transplants recipients. This study critically appraised the psychometric properties of those instruments and their ability to consider spe-cific concerns of liver transplant population. The authors concluded that none of the current instruments have considered certain key issues of transplant recipients, such as postsurgical complications (e.g. incisional pain, herniated wounds, scars, and deformity caused by opera-tion), anxiety associated with the fear of an unsuccessful transplant, risk of malignancy and opportunistic infec-tions, long term drug side effects, relapse and recurrence of the underlying disease, diabetes and kidney failure. The authors believe that the development of a standard and specific instrument is necessary to understand the factors affecting the quality of life in liver transplant re-cipients (7).
1.2. Liver Transplantation in IranLiver transplant has been performed in Iran since 1993. Until 2000, only forty liver transplants had been per-formed. This number rose to 400 cases between 2000 and 2007, and now more than 1600 liver transplants have been reported. According to the latest studies, the survival rate of recipients in the first and sixth years after transplantation were 84% and 82% respectively (8). Due to the growing number of liver transplant recipients, there is a need to assess their quality of life via a standard and context-based instrument. The importance of context is to the extent that the World Health Organization has defined the quality of life as individuals’ perception of their status in life, cultural and value systems in relation to goals, expectations, standards and concerns. Similar to international context, there is no standard, context-sensi-tive quality of life instrument specific to liver transplant recipients in Iranian context.
2.ObjectivesTherefore, the aim of this study was to design and es-tablish a specific instrument for measuring the quality of life in liver transplant recipients.
3. Materials and MethodsThis study was a methodological research. This method is often used when the aim of the study is to design or validate an instrument (9). To develop the instrument, combinations of inductive and deductive approaches were used. The development process of this instrument 
was completed through two sequential phases including the item generation and the item reduction over a two year period, from 2010 to 2012.
3.1. Item GenerationIn this step, the results of a qualitative study with con-ventional content analysis approach (10) was used to extract the definition and related items of quality of life based on real experiences of liver transplant recipients. In this study, which recruited 9 cases of liver transplant recipients, semi structured interviews were used to col-lect data. Based on the analysis of these data, the initial items related to quality of life were extracted. After that, these extracted items were verified and completed by in-ternational literatures. This review included an extensive literature review on quality of life resources, particularly previous qualitative studies, and also existing quality of life instruments, specifically Ferrans and Powers’ quality of life questionnaire. In addition, throughout the selec-tion of items and designing the initial questionnaire, suggestions and necessary considerations related to shortcomings of current instruments offered by Jay et al. were regarded. Finally, the initial questionnaire (item pool) with 59 items was provided for the second phase of the study. This phase lasted about 6 months.
3.2. Item ReductionIn this phase, psychometric properties of initial instru-ment were evaluated, and necessary modifications were performed. Through this phase, evaluating the instru-ment’s validity and reliability as well as reducing its items and demonstrating its dimensionality was performed. 
3.2.1. Face ValidityTo confirm the face validity, four liver transplant recipi-ents were individually interviewed. Clarity, ambiguity and difficulty of each item were reviewed and discussed. Finally, ambiguous and obscure words and sentences were adjusted.
3.2.2. Content ValidityTo ensure the content validity, we used a quantitative approach in the form of the content validity index (CVI) of-fered by Waltz and Baussel (11). For this reason, eleven ex-perts involved in liver transplant, including nurses, liver transplant coordinators, and specialists of Gastroenterol-ogy were asked to determine the item relevancy using a four-point ordinal rating scale (1: irrelevant; 2: somewhat relevant; 3: quite relevant; 4:highly relevant) (12). Based on the Lynn guidelines on acceptable CVI score, 0.70 was seemed as the cut point for determining whether each item should be removed or preserved (13). Moreover, the experts were encouraged to express further comments and suggestions.
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3.2.3. Recheck Face ValidityAt this stage to ensure the accountability and compre-hensibility of the questions, individual interviews were conducted with three liver transplant recipients.
3.2.4. Construct ValidityTo ensure the construct validity, exploratory factor anal-ysis was used. Principal Component Analysis and Vari-max Rotation Method were used to extract the factors. At first, the questionnaire was completed by 250 liver transplant recipients (14). Convenience sampling was used in this stage due to patients’ country-wide distribu-tion and difficulties to approach them. For that reason, some recipients who referred to transplantation clinic of Namazi Hospital in Shiraz, a center of liver transplan-tation in Iran, volunteered to fill out the questionnaire. Informed consent was obtained from all recipients for participating in the study. To enter this study, recipients had to be at least 18 years old to ensure they understood various aspects of quality of life. Besides, they were sup-posed to receive their transplant not less than 6 months before that time, because it is expected that the patient's social rehabilitation would start 6 months after the trans-plantation (15).A receptionist at the transplant clinic, who was famil-iar with the clinical status and patients, was in charge of completing the questionnaires and addressing partici-pants’ potential concerns. In case the patient was illiter-ate, the receptionist or someone close to the patient com-pleted the questionnaire. Data collection in this phase lasted one year, from September 2011 to September 2012.
3.2.5. Convergent ValidityAt this stage, 22 respondents were asked to fill out the 
developing questionnaire as well as an Iranian version of sf-36 quality of life questionnaire (16).
3.2.6. ReliabilityInternal consistency of items was achieved by using Cronbach's Alpha. We used SPSS software (version 13th), Pearson correlation test, exploratory factor analysis and Cronbach's alpha for the analysis.
3.2.7. Ethical ConsiderationsThis research was approved and authorized by the eth-ics committee of Research Centre at Tehran University of Medical Sciences.
4. ResultsThrough the item generation phase, the initial ques-tionnaire structured with 59 items was formed. In face va-lidity stage, some items were revised and adjusted based on participant’s comments to improve their clarity and comprehensibility. For example, the item of "lack of in-volvement in deciding the treatment plan" was replaced with the item of “not involving the patients in their treatment plan". During the evaluation of content valid-ity, from initial version of questionnaire nine items with CVI scores of less than 0.70 were omitted (items number 8, 39, 42, 43, 47, 55, 56, 57, and 58) and two items (28 and 29) were merged together due to their conceptual simi-larities. Therefore, the number of items was reduced to 49 (Table 1). Then, the questionnaire was reviewed with a number of liver transplant recipients to correct minor ambiguities. Moreover, the questionnaire was revised by a Persian Language expert to ensure the accuracy of grammar and text articulacy. 
Table 1. Item lists Before the Factor Analysis
List of Terms Response Category
How satisfied are you with? very satisfied to very unsatisfied1. Health status2. The amount of energy needed for ordinary routine activities3. Ability to care for themselves without help from others4. Ability to take on the responsibilities of family5. Ability to meet financial needs6. Ability to do fun activities and sports7. Receive emotional support from family8.Receive support from special foundations and charitiesa9. Employment status (i.e., the ability to work at the moment)10. Marital relationships and sex11. Happiness and tranquility in the family12. Tranquility of spirit13. Relationship and Closeness with God
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14. Appearance15. Sense of vitality and exuberance16. Achievement level of personal goals17. Sense of control over life issues18. Being useful to others19.How to provide care after discharge and receiving training by the transplant team a20.How to Provide psychology and counseling services after transplantation a21.How people treat you as an individual who had liver trans-plant a22. Back to normal life after liver transplantation23. Life satisfaction in general
How worried are you with? very worried to very unworried24. The cost of immunosuppressant drugs25. Obtain immunosuppressant drugs26. Taking several drugs simultaneously and forever27. Possibility of Medical complications28.Problems related to marriage and childbearing a29. Financial costs generated following liver transplantation30. The feeling of being a burden to family and society31. Uncertainty about a happy, healthy and desired future32. Lack of access to medical members of transplant team when necessary33. Lack of available physicians familiar with transplantation issues in home town34. Not care about your opinions in the treatment process35. Lack of awareness and sufficient information about self-care36. Recurrence of the underlying disease37. Transplant rejection38.Life In exchange for death of another person a
How problematic for you? very problematic to no problem39. Weakness and fatigue40.Unusual increased appetite a41.Pain in site of operation a42. Scar formation in operation site43. Biliary ducts complications44.Unusual weight gain45. Developed hyperglycemia after Transplantation46. Developed hypertension after Transplantation47. Difficulty in renal function (creatinine increase in experi-ments)48.Hand tremor a49. Osteoporosis (diagnosed by a physician)a deleted items in final version (after factor analysis)
In the next step, prepared questionnaire was changed to a Likert scale format, and was given to 250 liver trans- plant recipients. A total of 250 liver transplant recipients completed the questionnaire. The mean age of partici-
Parsa Yekta Z et al.
5Hepat Mon. 2013;13(10):e9701
pants was 37 years with an average of 3 years post-trans-plant; 63% of the samples were men. 70% of the partici-pants were married. Most of the subjects (40%) had a high school diploma or above, and approximately 44% of them were employed. Most patients had either hepatitis B or cirrhosis before transplantation. The results are shown in Table 2.After the descriptive analysis of the data, the apprais-ing of the appropriateness of data for factor analysis was considered. In this way, two main tests including Kaiser-Meyer-Olkin (KMO) Measure of Sampling Adequacy (17) and Bartlett's Test of Sphericity (18) were performed. Ac-cording to the results of KMO = 0.709 and Bartlett's test = 2628.236 (P <0.001), it could be concluded that using factor analysis regarding sample adequacy and dimen-sionality was possible.
Table 2. Demographic Characteristics of Participants (n = 250)
Data
Age, y, Mean ± SD 37.5 ± 12
Sex, %Male 63.3Female 36.7
Education, %Academic education 19.6Diploma and under diploma 80.4
Marital status, %Married 69.7Single 30.3
Employment, %Employed 44.6Unemployed 21.1Housekeeper 24.4Student 9.9
Underlying disease, %Hepatitis 25.2PSC 12.6Cirrhosis 42.1Autoimmune 5Others 15.1
The results of the analysis were as follows: First, explor-atory factor analysis was conducted with a minimum load factor and regardless of the number of factors, 14 factors were extracted at this stage. Since the scree plot showed three or four main factors, further analysis was performed with three and then with four factors. At the end, three-factor analysis seemed to be more practical. These three factors with a cumulative variance of more than 40% covered most of the total observed variance (Table 3). The chosen threshold for factor loads was 0.4. 
Therefore, nine items including questions 8, 19-21, 28, 38, 40, 41, and 48 were deleted. Only one item was cross load (item 31) and although factor load of this item in the first factor was higher (0.516) than the second factor (0.411), the concept of this item was closer to the second factor and so was located there (Table 3). The results showed that the first factor was accompanied by the maximum loading of questions 1-7, 9-18, 22, 23, 30, and 39 (Table 1). The second factor was accompanied by the maximum loading of questions 24-27, 29, 31-37, and the third factor by questions 42-47, and 49. Therefore, the questionnaire was reduced to 40 items. These three factors were named based on the shared meaning of their related items as “Health satisfaction”, “Concerns”, and “Complications” (Table 4). Convergent validity was evaluated by assessing the consistency of the questionnaire with scores of Irani-an version of Sf-36 questionnaire. The consistency score was 0.35, and Cronbach's alpha score of each factor was more than 0.7, and the internal consistency score of all the items was 0.922 in total (Table 4). 





q1 0.666 0.160 0.167
q2 0.599 -0.053 0.010
q3 0.741 -0.010 -0.048
q4 0.721 0.130 -0.034
q5 0.555 0.385 -0.220
q6 0.751 0.072 -0.046
q7 0.481 0.143 0.155
q8 0.170 0.371 -0.006
q9 0.590 0.182 -0.140
q10 0.578 0.245 0.043
q11 0.723 0.054 0.204
q12 0.711 0.192 0.096
q13 0.514 0.021 0.215
q14 0.722 0.191 -0.106
q15 0.811 0.175 0.055
q16 0.736 0.348 -0.148
q17 0.810 0.072 0.112
q18 0.716 0.002 0.019
q19 0.097 0.259 0.312
q20 0.241 0.237 0.245
q21 0.262 0.172 0.044
q22 0.660 0.184 0.107
q23 0.606 0.262 0.129
q24 0.290 0.673 -0.191
q25 0.178 0.701 -0.137
q26 0.376 0.584 0.017
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q27 0.150 0.498 0.127
q28 0.339 0.323 0.221
q29 0.356 0.675 -0.119
q30 0.538 0.370 0.060
q31 0.516 0.411 0.189
q32 0.098 0.559 0.237
q33 0.072 0.464 0.337
q34 0.130 0.680 0.281
q35 -0.073 0.416 0.325
q36 0.127 0.683 0.126
q37 0.054 0.535 -0.066
q38 -0.081 0.209 0.095
q39 0.439 0.267 0.311
q40 0.141 0.283 -0.016
q41 0.155 -0.003 0.263
q42 -0.014 0.265 0.541
q43 0.290 0.130 0.456
q44 -0.166 -0.016 0.528
q45 -0.092 0.085 0.748
q46 -0.085 0.138 0.753
q47 0.146 -0.038 0.639
q48 0.081 -0.198 0.381
q49 0.089 0.039 0.600
Eigenvalue 12.63 4.216 3.11
Explained variance, % 21.118 11.440 8.172




(SD)a Skew-ness Cronbach’ alpha
Health Sat-
isfaction
21 67.113 (11.968) -0.824 0.92
Concerns 12 31.194 (8.223) 0.001 0.84
Complica-
tions
7 23.613 (4.496) -1.560 0.76a Scores range from 21 to 84 for Health Satisfaction, 12 to 48 for Concerns, and 7 to 28 for Complication. Higher scores indicate better quality of life
These items were placed in three parts based on identi-fied factors. All of them were evaluated based on a four-point Likert scale, in a way that in every part, 1 shows the least desirable response, and 4 the most desirable one. For example, in the first part that assesses (evalu-ates) “health satisfaction”, number 1 is “very dissatisfied”, number 2 “fairly dissatisfied”, number 3 “fairly satisfied”, and 4 “very satisfied”. The total score of this question-naire can be a minimum of 40 to a maximum of 160. The average time to complete this paper-and-pencil question-
naire was approximately 15 minutes.
 5. DiscussionThe final questionnaire consisted of 40 items, and three factors of health satisfaction, concerns and complica-tions. The first factor is health satisfaction which covers most items and defines health according to the World Health Organization definition. This factor covers all aspects of health including physical, mental, spiritual, and social. Considering that the ultimate goal of liver transplantation is returning the patient to active life, satisfaction with all aspects of this factor is necessary. The second factor is concerns. This factor is related to concerns of liver transplant recipients in various areas, particularly follow-up issues and costs. These concerns upset the transplant recipients and influence their life satisfaction level after the transplantation. The third fac-tor that is called complications includes physical prob-lems and possible complications after liver transplanta-tion. Although some of these complications are observed in other solid organ transplant recipients, some of these such as bile duct problems, and recurrence of the under-lying disease are specific to liver transplant recipients. Occurrence of these complications has negative impacts on patients’ quality of life. Perhaps the only question-naire developed for liver transplant recipients is Ferrans and Power. This questionnaire has two parts (satisfaction and importance) with a total of 70 questions which mea-sures quality of life. It evaluates different aspects such as health and activities, psychological and emotional, so-cial/economic, and family relationships. In this question-naire most items are common among all versions, and in each version a few items are included to suite a particu-lar disease. In the liver transplantation version, there are two specific items related to liver transplantation. These items evaluate the satisfaction and importance of hav-ing a liver transplant. Nonetheless, qualitative studies that assessed quality of life in liver transplant recipients, have reported several factors affecting patients’ life. Fear of transplant rejection was addressed as one of the issues which affects the quality of life in the case studies (19, 20). Need for support after discharge, participation in deci-sions related to care, willingness to participate in social activities, and physical complications such as increased appetite, trembling hands, and high blood pressure were other issues (21-24).Therefore, we saw the necessity and value of designing a questionnaire regarding the issues that liver transplant recipients are dealing with. All of the 40 items of the questionnaire were selected with the intention of briefly addressing specific issues of trans-planted patients. Psychometric evaluations resulted in adequate reliability and validity of the questionnaire. An example can be seen in Ferrans & Power reports on the validity and reliability (Cronbach's alpha of 0.73 to 0.99 and correlation of 0.87 in the test-retest interval of two weeks – content, convergent and structure validity). How-
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ever, in assessing the convergent validity, compared to the Ferrans & Power questionnaire, we faced a mediocre correlation coefficient which was probably due to our in-sufficient sample size. However, it seems that this ques-tionnaire is more practical, shorter and more specific in comparison with other available questionnaires.The purpose of this study was to design a valid and re-liable instrument for evaluating quality of life in liver transplant recipients. Evidence shows that the available instruments measuring this concept are somewhat lack practicality. Therefore, we tried to design a tool to ad-dress the issues and needs ignored in previous question-naires. A method combining inductive and deductive approaches was used. In the process of psychometric evaluation of the questionnaire, face, content, construct and convergent validity and internal consistency of the questionnaire were assessed. Finally, 40 items of the questionnaire were covered by three factors: health sat-isfaction, concerns and complication. Four-point Likert scale was used for giving scores to this instrument. Some important variables affecting the patients’ quality of life which were previously neglected are considered in this questionnaire. Variables such as concerns about the pos-sibility of transplant rejection, cost and complication of immunosuppressive drugs, recurrence of the underlying disease, and the need for transplant medical team follow-ups. It is clear that the use of this questionnaire instead of the common tools can be viewed as a more accurate cri-terion to assess the outcomes of liver transplants. Since solid organ transplant recipients have similar issues, this tool can be used with other transplant recipients, includ-ing kidney and kidney –pancreas recipients. However, there is a need to profoundly study this matter.Using a nonrandom sampling was the main limitation of this study. However, the descriptive statistics indicated that samples are quite diverse in age, sex, marital status, education level, and underlying diseases.
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